Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
UN rights chief says uncovered remains in Gaza raise concerns of war crimes
Italian NATO jet downs suspected Russian drone over Lithuania
Indian police to query Google over 500,000 fake Gmail IDs linked to bomb hoax
Saudi Arabia says danger passed in six cities, including Yanbu
